Chris Diorio, director of Research and Development at PharmaCann, talks about the company’s new cannabis oral dosage form, designed to ensure cannabis is absorbed better and lasts longer, and to improve the quality of life for patients who don’t like smoking cannabis or who want to take fewer doses.
https://www.businesswire.com/news/home/20180806005164/en/PharmaCann-Capsules-Offer-New-Option-Medical-Cannabis
